Excellere Partners’ most common sectors for investment arehealthcare services (32%) and life science (16%) . The Firm’s most common investment types include growth capital (56%) and buyout (lbo, mbo, mbi) (32%). In total, Excellere Partners has invested in 20 US states.
Sign-up to view Excellere Partners’ full profile and discover more large private equity firm investors just like it.
3033 East First Avenue, Suite #700,
Denver,
Colorado
80206
United States
(303) 765-2400
www.excellerepartners.com
dkessenich@excellerepartners.com
| Status | Dates | Company | Description | |
|---|---|---|---|---|
| Investment | Exit | |||
| Current | 2021-10-01 | - |
Molecular Designs
Life Science Birmingham, Alabama www.moleculardesigns.com |
Molecular Designs is a developer, manufacturer, and supplier of multiplex assays for molecular testing and research. Utilizing time-tested PCR to identify pathogens rapidly not only improves patient care but also advances antibiotic stewardship. Molecular Designs was founded in 2019 and is based in Birmingham, Alabama.
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
